A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)
- All Author(s)
- Y. H. Park
; T. Y. Kim
; G. M. Kim
; K. H. Jung
; S. Y. Kang
; I. H. Park
; J. H. Kim
; K. E. Lee
; H. K. Ahn
; M. H. Lee
; H. J. Kim
; J. I. Lee
; S. J. Koh
; J. Y. Kim
; K. H. Lee
; J. Sohn
; S. B. Kim
; Y. H. Im
; S. A. Im
- Intsitutional Author(s)
- 김한조
- Issued Date
- 2019
- Type
- Conference
- Conference Name
- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
- Conference Date
- 43616
- dc_citation_conferenceCountry
- Chicago, IL, United States
- Citation Publisher
- American Society of Clinical Oncology
- Citation Title
- Journal of Clinical Oncology. Volume 37, Number 15_suppl
- Citation Start Page
- 1007
- Citation End Page
- 1007
- Language(ISO)
- eng
- DOI
- 10.1200/JCO.2019.37.15_suppl.1007
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/4539
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.